Avi-Dekel is a CBD-rich hybrid developed in Northern Israel, where breeders sought a daytime-friendly balance. It leans indica-dominant, with about a 60:40 indica to sativa ratio, yielding steady relaxation without a heavy cerebral rush. With cannabidiol as the primary active component and only trace psychoactivity, this strain tends to keep the mind clear while easing physical tension. The buds display gold and olive-green hues that catch the light and hint at a resinous, robust structure.
Medically, Avi-Dekel has built a reputation for addressing a range of concerns from digestive discomfort and sleep disturbances to arthritis, inflammation and fatigue. People report relief from pain and cramping, improved appetite for some, and a mood lift that helps reduce stress without a conspicuous high. Side effects are minimal, making it a practical option for patients who need therapeutic benefits yet want to stay productive and present.
In aroma and flavor, Avi-Dekel offers an earthy baseline with nutty accents and a piney, sweet undercurrent, finishing with a woody edge. The tasting notes align with the sensory profile, while the overall effect tends to be uplifting and sociable paired with gentle physical relaxation, fostering focus and happiness. As a relatively new cultivar in the cannabis landscape, it stands as a testament to Israel’s ongoing breeding efforts to expand CBD-dominant options.